Zobrazeno 1 - 10
of 335
pro vyhledávání: ''
Publikováno v:
Perfusion. 38:270-276
Background: Levosimendan (LEVO) is a positive inotropic drug which could increase myocardial contractility and reduce the mortality rate in cardiac surgical patients. However, Whether LEVO is associated with postoperative bleeding and blood transfusi
Autor:
Kim R. Derespina, Shivanand S. Medar, Taylor Cohen, Shubhi Kaushik, Mark Shlomovich, Swati Chandhoke, Giles J. Peek, Dhara D Shah
Publikováno v:
Perfusion. 38:58-65
This study describes the use of bivalirudin in children on extracorporeal membrane oxygenation (ECMO). Pediatric patients receiving bivalirudin were compared to patients receiving heparin as the anticoagulant on ECMO. Data was collected for children
Autor:
Ryota Inokuchi, Naoko Ohashi-Fukuda, Tatsuma Fukuda, Ichiro Kukita, Aya Matsudaira, Takumi Chinen, Hiroshi Sekiguchi, Hirotsugu Kaneshima
Publikováno v:
Perfusion. 37:835-846
Objective: Current guidelines for cardiopulmonary resuscitation (CPR) recommend that standard-dose epinephrine be administered every 3–5 minutes during cardiac arrest. However, there is a knowledge gap regarding the optimal epinephrine dosing inter
Publikováno v:
Perfusion. 37:825-834
Objectives: Post-cardiotomy cardiogenic shock is an infrequent but important cause of death following cardiac surgery. Extra-corporeal membrane oxygenation offers the opportunity for temporary cardiovascular support and myocardial rest, with a view t
Autor:
Wayne Moore, Nadji Giliam, Arun Chopra, Tracy Low, Daniel Marino, Peter Nikolos, Jillian Deacon, Jeffrey J. Cies, Adela Enache
Publikováno v:
Perfusion. 37:729-737
Introduction: To determine the oxygenator impact on alterations of meropenem (MEM)/vaborbactam (VBR) in a contemporary neonatal/pediatric (1/4-inch) and adolescent/adult (3/8-inch) extra corporeal membrane oxygenation (ECMO) circuit including the Qua
Autor:
Silvia Arpicco, Paola Milla, Fiorenza Ferrari, Alessandra Rizza, Chiara Giorni, Cristiana Garisto, Roberta Haiberger, Simona Benegni, Maria Giovanna Quattrone, Zaccaria Ricci, Eleonora Marinari, Elisabetta Muntoni
Publikováno v:
Perfusion. 37:553-561
Introduction: Few data are available regarding intraoperative plasma concentrations of vancomycin administered as prophylaxis in pediatric cardiac surgery. The aims of this study were to investigate during pediatric cardiac surgery with cardiopulmona
Publikováno v:
Perfusion. 37:208-215
Objective: The purpose of this study was to explore the effect of sacubitril-valsartan on rats with acute myocardial infarction. Methods: Sprague-dawley rats were randomly divided into six groups. Rats in Group A and B were threaded without deligatio
Publikováno v:
Perfusion. 37:78-85
Objective: To evaluate the effect of individualized antiplatelet therapy, based on CYP2C19 genotyping, on platelet function in patients underwent PCI and to compare this treatment with conventional antiplatelet therapy. Methods: All patients were tre
Autor:
Glenn J. Whitman, Chun Woo Choi, Salia Farrokh, Katharine T. Clark, Michael C. Grant, Sung Min Cho, Megan F. Hunt
Publikováno v:
Perfusion. 36:868-872
Introduction: Extracorporeal membrane oxygenation (ECMO) is a life-saving therapy for those in cardiopulmonary failure, including post-cardiac arrest. Despite a high volume of ECMO patients using anti-seizure medication, there is a paucity of data co
Publikováno v:
Perfusion. 36:694-703
Background: Levosimendan (LEVO), is an inotropic agent which has been shown to be associated with better myocardial performance, and higher survival rate in cardiac surgical patients. However, preliminary clinical evidence suggested that LEVO increas